New FDA/EMA rare diseases and patient engagement clusters underway

By: Jonathan Goldsmith, M.D., FACP, and Sandy Kweder, M.D., RADM (Ret.) US Public Health Service Drug development and approval happens across the globe and we at FDA strive to collaborate with other countries and international regulatory agencies to ensure public … Continue reading →

Source: FDA Voice - October 18, 2016 Category: American Health Source Type: blogs